UNIGE document Scientific Article
previous document  unige:27063  next document
add to browser collection

Défis de la co-infection par le virus de l’hépatite C et le VIH

Published in Revue médicale suisse. 2012, vol. 8, no. 338, p. 905-10
Abstract HIV and HCV share transmission routes and, for this reason, 25% of HIV patients are also infected by HCV, and up to 80% of HIV-positive iv drug users. AIDS incidence and mortality are not higher in HCV positive patients, but liver morbidity and mortality are increased. Spontaneous clearance of HCV after infection is less frequent among HIV positive patients. Liver fibrosis progresses faster in HIV-HCV co-infected patients compared to HCV mono-infected, but this can be partially slowed down with effective antiretroviral therapy and immune restoration. Response to HCV treatment is also weaker among co-infected patients. Pharmacological interactions and increased toxicity of antiretroviral drugs and anti-HCV drugs are challenging for clinicians, especially if the recently approved anti-HCV proteases are used.
Keywords Anti-Retroviral Agents/administration & dosage/therapeutic useCoinfection/epidemiology/therapyDisease ProgressionHIV Infections/complications/epidemiology/therapyHIV-1/physiologyHepacivirus/physiologyHepatitis C/complications/therapyHumansModels, Biological
PMID: 22611628
Full text
Article (Published version) (588 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research groups Unité HIV (46)
Etudes et traitement de l'hépatite C et B (554)
(ISO format)
AMBROSIONI CZYRKO, Juan, NEGRO, Francesco, CALMY, Alexandra. Défis de la co-infection par le virus de l’hépatite C et le VIH. In: Revue médicale suisse, 2012, vol. 8, n° 338, p. 905-10. https://archive-ouverte.unige.ch/unige:27063

424 hits

1 download


Deposited on : 2013-03-26

Export document
Format :
Citation style :